Shi, H., Yin, W., Zhang, H., He, J., Zhang, S., Wang, T., Jiang, X., Wen, J., Zhu, G., Cao, W., Cobbold, M., Shen, L. (2025). AZD0120 (GC012F), a BCMA/CD19 dual-targeting fastcar T-cell therapy, demonstrates potent preclinical efficacy in multiple myeloma. Blood. https://doi.org/10.1182/blood-2025-7642